Clinical Trial Update: Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update from NIAID investigates immune changes in the liver allograft and circulation during liver transplantation; the study is not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Liver Transplant | Phase 2 | Status: NOT_YET_RECRUITING